Express News | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$271.1K in Common Stock
$Cytokinetics(CYTK.US)$ Director PARSHALL B LYNNE sold 5,000 shares of common stock on Jul 1, 2024 at an average price of $54.22 for a total value of $271.1K.Source: Announcement What is statement of
Cytokinetics(CYTK.US) Officer Sells US$621.58K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Blum Robert I sold 11,500 shares of common stock on Jul 1, 2024 at an average price of $54.05 for a total value of $621.58K.Source: Announcement What is statement of ch
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 271.09K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Director B LYNNE PARSHALL intends to sell 5,000 shares of its common stock on Jul 1, with a total market value of approximately $271.09K. B LYN
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 621.62K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 11,500 shares of its common stock on Jul 1, with a total market value of approximately $621.62K. ROBERT BLU
Unusual Options Activity: CTLT, STX and Others Attract Market Bets, CTLT V/OI Ratio Reaches 250.0
EST Jul 1st Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Cytokinetics(CYTK.US) Officer Sells US$392.14K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Malik Fady Ibraham sold 7,300 shares of common stock on Jun 25, 2024 at an average price of $53.72 for a total value of $392.14K.Source: Announcement What is statement
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 392.17K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 25, $Cytokinetics(CYTK.US)$ Officer FADY MALIK intends to sell 7,300 shares of its common stock on Jun 25, with a total market value of approximately $392.17K. FADY MALIK
Cytokinetics Is Maintained at Overweight by JP Morgan
Cytokinetics Is Maintained at Overweight by JP Morgan
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $65
JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $77 to $65.
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $65
J.P. Morgan analyst Tessa Romero maintains $Cytokinetics(CYTK.US)$ with a buy rating, and sets the target price at $65.According to TipRanks data, the analyst has a success rate of 50.0% and a total a
Express News | Cytokinetics Inc : JP Morgan Cuts Target Price to $65 From $77
Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5
EST Jun 21st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
This Insider Has Just Sold Shares In Cytokinetics
We wouldn't blame Cytokinetics, Incorporated (NASDAQ:CYTK) shareholders if they were a little worried about the fact that Robert Blum, the CEO, President & Director recently netted about US$1.2m selli
Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$262.75K in Common Stock
$Cytokinetics(CYTK.US)$ Director PARSHALL B LYNNE sold 5,000 shares of common stock on Jun 17, 2024 at an average price of $52.55 for a total value of $262.75K.Source: Announcement What is statement o
Cytokinetics(CYTK.US) Officer Sells US$1.18 Million in Common Stock
$Cytokinetics(CYTK.US)$ Officer Blum Robert I sold 22,500 shares of common stock on Jun 17, 2024 at an average price of $52.6 for a total value of $1.18 million.Source: Announcement What is statement
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 1.18 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 22,500 shares of its common stock on Jun 17, with a total market value of approximately $1.18 million. ROB
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
Robert I Blum, Director, President & CEO, on June 17, 2024, sold 22,500 shares in Cytokinetics (CYTK) for $1,183,391. Following the Form 4 filing with the SEC, Blum has control over a total of 420,811